Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3CRRN9
Fri, 11.04.2025
Cherry SE
Munich, 11 April 2025 – While preparing the consolidated financial statements for fiscal year 2024 and in close coordination with its auditor, Cherry SE has recognized impairments on assets totaling EUR 28.6 million. This amount includes EUR 7.9 million related to goodwill, EUR 15.8 million related to other non-current assets, and EUR 4.9 million r [ … ]
Mon, 31.03.2025
Cherry SE
Munich, 31 March 2025 – With gematik’s provider approval for its SmartLink technology, CHERRY Digital Health has achieved a significant milestone in advancing digital healthcare. This solution facilitates the secure and user-friendly dispensing of e-prescriptions via the electronic health card (eGK) using NFC-enabled smartphones, ensuring seamless, [ … ]
Thu, 27.02.2025
Cherry SE
Munich, 27 February 2025 – Cherry SE announces additional preliminary group key figures, along with divisional sales and results for the last fiscal year.
As previously announced on 11 February 2025, Cherry SE concluded the 2024 financial year with a consolidated group revenue of approximately EUR 110 million and an adjusted EBITDA margin of aroun [ … ]
Mon, 17.02.2025
Cherry SE
Munich, 17 February 2025 – Charlotte Johs steps down from the Supervisory Board of Cherry SE as she intends to join the Board of a Danish Company.
Cherry SE announced today that Charlotte Johs has decided to step down from her position on the Supervisory Board of Cherry SE, effective 28 February 2025. Ms. Johs has been nominated and intends to ass [ … ]
Wed, 12.02.2025
Cherry SE
Munich, 12 February 2025 - Dr. Philip Groth will take over the position of Managing Director of Cherry Digital Health GmbH, a subsidiary of Cherry SE, on March 1, 2025.
On 1 March 2025, Dr. Groth, an experienced manager in the pharma and health tech space with a focus on leadership, business growth, governance and strategic transformation will tak [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2025 - Starting in 2025, Cherry SE will discontinue quarterly forecasts and instead prioritize a reliable full-year outlook.
Given the volatility of the capital markets and business environment, the Management Board has decided to discontinue quarterly forecasts in 2025 and instead focus on a reliable full-year outlook. This de [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2025 - Subdued trends in the Americas and increasing competitive disadvantages in the switch business are weighing on Group revenue in the fourth quarter of 2024. According to the current state of assessment, Cherry SE's annual revenue for 2024 is therefore below the forecast of around EUR 120 million. The profound structural ad [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2024 - According to preliminary and as yet unaudited figures for the financial year 2024, Group revenue and the adjusted Group EBITDA margin* will not reach the forecast last updated on October 22, 2024. In 2024 as a whole, Group revenue is expected to amount to around EUR 110 million (forecast: around EUR 120 million) and the a [ … ]
Thu, 16.01.2025
Cherry SE
Munich, 16 January 2025 – Alexander Hecker will take over the position of Senior Vice President Global Peripherals of the newly designed business at CHERRY on February 1, 2025. Peripherals combines the sales and marketing of all products from the gaming, office, hygiene, and security sectors for a uniform go-to-market approach in our sales channels [ … ]